The comorbidities of obesity
- 1 October 2001
- journal article
- Published by Wiley in Practical Diabetes International
- Vol. 18 (8), 293-296
- https://doi.org/10.1002/pdi.274
Abstract
Obesity is a major risk factor for a number of diseases. It has direct effects on glucose and lipid metabolism and on blood pressure, leading via these to type 2 diabetes, coronary heart disease and cerebrovascular disease. These comorbidities are particularly associated with excess intra‐abdominal fat. Other important diseases which obesity increases the risks of include obstructive sleep apnoea, osteoarthritis of weight‐bearing joints and a number of types of cancer. In addition to these medical comorbidities obesity has many adverse social and psychological costs. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- Knee osteoarthritis and obesityInternational Journal of Obesity, 2001
- Obesity, overweight and patterns of osteoarthritis: the Ulm Osteoarthritis StudyJournal of Clinical Epidemiology, 2000
- The role of TNFα and TNF receptors in obesity and insulin resistanceJournal of Internal Medicine, 1999
- Fasting gall bladder volume and lithogenicity in relation to glucose tolerance, total and intra-abdominal fat masses in obese non-diabetic subjectsInternational Journal of Obesity, 1998
- The Effect of Age on the Association between Body-Mass Index and MortalityNew England Journal of Medicine, 1998
- Social and Economic Consequences of Overweight in Adolescence and Young AdulthoodNew England Journal of Medicine, 1993
- Insulin resistance, diabetes, and risk markers for ischaemic heart disease in Asian men and non-Asian in Bradford.Heart, 1992
- Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South AsiansThe Lancet, 1991
- Prospective study of attainment of social class of severely obese subjects in relation to parental social class, intelligence, and education.BMJ, 1986
- Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.Circulation, 1983